Novel human papillomovirus immunogenic compositions and the offer for using it. The composition includes the specific choice and design of unique multi-epitope peptide sequence, be that effective processing and intersection are presented to T cell. Peptide shows high level combination and HLA-supertypes for composition. Immunogenic composition is the target group for being widely applicable for large scale. The composition includes adjuvant, such as cation lipid.